![]() |
|
|
Vol. 16, Issue 11, 5433-5444, November 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



* Laboratory of Molecular Genetics, RIKEN Tsukuba Institute, Tsukuba, Ibaraki 305-0074, Japan;
Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki 305-8577, Japan
Submitted August 8, 2005;
Revised August 29, 2005;
Accepted September 2, 2005
Monitoring Editor: William Tansey
Small ubiquitin-related modifiers (SUMOs) are proteins that are posttranslationally conjugated to diverse proteins. The c-myb proto-oncogene product (c-Myb) regulates proliferation and differentiation of hematopoietic cells. PIASy is the only known SUMO E3 ligase for c-Myb. Here, we report that TRAF7 binds to c-Myb and stimulates its sumoylation. TRAF7 bound to the DNA-binding domain of c-Myb via its WD40 repeats. TRAF7 has an E3 ubiquitin ligase activity for self-ubiquitination, but TRAF7 also stimulated the sumoylation of c-Myb at Lys-523 and Lys-499, which are the same sites as those used for PIASy-induced sumoylation. TRAF7 inhibited trans-activation induced by wild-type c-Myb, but not by the sumoylation site mutant of c-Myb. The expression of both c-myb and TRAF7 was down-regulated during differentiation of M1 cells. Endogenous TRAF7 localized to both the cytoplasm and nucleus of M1 cells. Consistent with this, significant amounts of sumoylated c-Myb were found in the cytoplasm of M1 cells, whereas nonsumoylated c-Myb was found predominantly in the nucleus. Overexpressed TRAF7 was localized in the cytoplasm of CV-1 cells, and sequestered c-Myb and SUMO1 in the cytosol, whereas PIASy was localized in the nucleus. Thus, TRAF7 negatively regulates c-Myb activity by sequestering c-Myb to the cytosol via sumoylation.
Abbreviations used: c-Myb, c-myb proto-oncogene product; DBD, DNA-binding domain; NLK, Nemo-like kinase; NPCs, nuclear pore complexes; NRD, negative regulatory domain; PIAS, protein inhibitors of activated STATs; SUMO, small ubiquitin-related modifier.
The online version of this article contains supplemental material at MBC Online (http://www.molbiolcell.org).
Address correspondence to: Shunsuke Ishii (sishii{at}rtc.riken.jp).
This article has been cited by other articles:
![]() |
C. Kanei-Ishii, T. Nomura, T. Takagi, N. Watanabe, K. I. Nakayama, and S. Ishii Fbxw7 Acts as an E3 Ubiquitin Ligase That Targets c-Myb for Nemo-like Kinase (NLK)-induced Degradation J. Biol. Chem., November 7, 2008; 283(45): 30540 - 30548. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. V. Pham, H.-J. Zhou, Y.-C. Lin-Lee, A. T. Tamayo, L. C. Yoshimura, L. Fu, B. G. Darnay, and R. J. Ford Nuclear Tumor Necrosis Factor Receptor-associated Factor 6 in Lymphoid Cells Negatively Regulates c-Myb-mediated Transactivation through Small Ubiquitin-related Modifier-1 Modification J. Biol. Chem., February 22, 2008; 283(8): 5081 - 5089. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Deyrieux, G. Rosas-Acosta, M. A. Ozbun, and V. G. Wilson Sumoylation dynamics during keratinocyte differentiation J. Cell Sci., January 1, 2007; 120(1): 125 - 136. [Abstract] [Full Text] [PDF] |
||||